Inactive Instrument

Calendar Hemispherx BioPharma, Inc Nyse

Equities

US42366C1036

End-of-day quote Nyse Other stock markets
- ^USD	-

29/04	AIM ImmunoTech Says Safety Evaluation of First Dose Level of Pancreatic Cancer Study Completed	MT
10/04	AIM Immunotech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer	CI

Chart calendar Hemispherx BioPharma, Inc

dfd85edc1fa.SqWUuu_1dmaKO8vfyVLtd1TW5kPXCvGZ5D-DEoiVHAA.AeT-zKmMOV7nA5mlmDyvRBu6qySQcqTPvXTITerxSGobwvyJibBEC_Nc-w~2ad6115ab448ea4612ed4a65753d2579

Upcoming events on Hemispherx BioPharma, Inc

16/05/2024	Q1 2024 Earnings Release (Projected)
13/08/2024	Q2 2024 Earnings Release (Projected)
15/11/2024	Q3 2024 Earnings Release (Projected)
07/04/2025	Q4 2024 Earnings Release (Projected)

Past events on Hemispherx BioPharma, Inc

03/04/2024 11:05 pm	MedInvest Biotech & Pharma Investor Conference
02/04/2024 06:00 pm	Q4 2023 Earnings Call
02/04/2024 05:00 pm	Q4 2023 Earnings Release
20/03/2024 09:30 pm	AIM ImmunoTech Virtual Investor Lunch Break Conference
05/01/2024	Annual General Meeting - Proxy Fight for Board Control
05/12/2023 10:30 am	Noble Capital Markets Emerging Growth Equity Conference
01/12/2023 09:30 pm	Annual General Meeting - Proxy Fight for Board Control
15/11/2023 07:00 pm	Q3 2023 Earnings Call
15/11/2023 06:00 pm	Q3 2023 Earnings Release
22/09/2023	Marie Sklodowska-Curie on Cancer Research and Care Symposium
11/09/2023 04:30 pm	H.C. Wainwright Global Investment Conference
15/08/2023 06:00 pm	Q2 2023 Earnings Call
15/08/2023 04:15 pm	Q2 2023 Earnings Release
12/07/2023 08:30 pm	Virtual Investor Summer Spotlight Conference
21/06/2023 09:30 pm	Maxim Group Virtual Healthcare Conference
16/05/2023 06:00 pm	Q1 2023 Earnings Call
15/05/2023 06:15 pm	Q1 2023 Earnings Release
03/04/2023 06:00 pm	Q4 2022 Earnings Call
03/04/2023 04:00 pm	Q4 2022 Earnings Release
18/01/2023 09:30 pm	Virtual Investor Conference

Annual results

Fiscal Period	December	2019	2020	2021	2022	2023	2024
Net sales Million USD	Released Forecast Spread	0,14 0,48 -71.09%	0,16 0,19 -14.66%	0,14 0,12 11.88%	0,14 0,24 -41.17%	0,20 0,16 28.66%	0,00
EBITDA	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00
EBIT Million USD	Released Forecast Spread	-12,4 -11,9 -4.73%	-15,0 -13,0 -15.83%	-17,1 -15,9 -7.09%	-19,9 -20,0 0.21%	-31,9 -24,3 -31.42%	-24,5
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-9,53 -11,0 13.11%	-14,4 -13,6 -5.53%	-19,1 -17,5 -9.2%	-19,4 -20,9 7.06%	-29,0 -21,6 -34.38%	-24,5
Net income Million USD	Released Forecast Spread	-9,53 -11,0 13.11%	-14,4 -13,4 -7.52%	-19,1 -17,9 -7%	-19,4 -20,3 4.28%	-29,0 -22,5 -28.57%	-24,5
EPS USD	Released Forecast Spread	-2,62 -3,73 29.66%	-0,45 -0,43 -5.47%	-0,40 -0,38 -6.19%	-0,40 -0,44 8.05%	-0,60 -0,45 -33.33%	-0,49
Announcement Date		30/03/20	31/03/21	31/03/22	31/03/23	01/04/24	-

Quarterly results

Fiscal Period	December	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1
Net sales Million USD	Released Forecast Spread	0,05 0,04 36.35%	0,03 0,10 -67%	0,03 0,14 -78.21%	0,02 0,02 40%	0,06 0,18 -69.51%	0,05 0,00 -	0,04 0,02 82.61%	0,05 0,02 91.67%	0,07 0,04 78.08%	0,00	0,00	0,00	0,10	0,00
EBIT Million USD	Released Forecast Spread	-5,67 -4,54 -24.85%	-3,15 -4,50 29.96%	-4,70 -3,60 -30.26%	-6,52 -4,55 -43.21%	-5,56 -5,62 1.12%	-4,30 -5,50 21.91%	-5,46 -5,13 -6.42%	-8,16 -5,58 -46.26%	-14,0 -6,37 -119.79%	-5,50	-5,50	-5,50	-5,50	-5,50
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-5,85 -4,24 -38.04%	-3,82 -4,50 15.11%	-4,85 -3,62 -33.95%	-6,39 -4,92 -29.78%	-4,39 -5,89 25.52%	-3,66 -5,50 33.44%	-4,91 -5,34 8.06%	-7,82 -5,76 -35.74%	-12,6 -5,53 -127.5%	-5,50	-5,50	-5,50	-5,50	-5,50
Net income Million USD	Released Forecast Spread	-5,85 -4,54 -28.74%	-3,82 -4,50 15.11%	-4,85 -3,62 -33.95%	-6,39 -4,92 -29.78%	-4,39 -5,89 25.52%	-3,66 -5,50 33.44%	-4,91 -5,34 8.06%	-7,82 -5,76 -35.74%	-12,6 -5,53 -127.5%	-5,50	-5,50	-5,50	-5,50	-5,50
EPS USD	Released Forecast Spread	-0,12 -0,09 -28.58%	-0,08 -0,09 11.11%	-0,10 -0,08 -33.33%	-0,13 -0,10 -30%	-0,09 -0,13 28%	-0,08 -0,11 27.27%	-0,10 -0,11 9.09%	-0,16 -0,12 -39.13%	-0,26 -0,09 -188.89%	-0,11	-0,11	-0,11	-0,11	-0,11
Announcement Date		31/03/22	13/05/22	15/08/22	14/11/22	31/03/23	15/05/23	14/08/23	14/11/23	01/04/24	-	-	-	-	-

Upcoming sector events for Hemispherx BioPharma, Inc

Today 03:30 pm	AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release
Today 04:00 pm	SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release
Today 04:00 pm	REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
Today 04:30 pm	AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
Today 08:30 pm	GENMAB A/S: Q1 2024 Earnings Release
Today 01:31 am	ASCENDIS PHARMA A/S: Q1 2024 Earnings Release
06/05/2024	FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected)
06/05/2024	KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release
06/05/2024	MERUS N.V.: Q1 2024 Earnings Release (Projected)
06/05/2024	VAXCYTE, INC.: Q1 2024 Earnings Release (Projected)

More events

Past sector events for Hemispherx BioPharma, Inc

Today	ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
Today	DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
Today	GERON CORPORATION: Q1 2024 Earnings Release
Today	KURA ONCOLOGY, INC.: Q1 2024 Earnings Release
Today	KEROS THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today	ALECTOR, INC.: Q1 2024 Earnings Release (Projected)
Today	ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release
Today	TRAVERE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
Today	ARDELYX, INC.: Q1 2024 Earnings Release
Today	ZYMEWORKS INC.: Q1 2024 Earnings Release